Petrie-Flom Interns’ Weekly Round-Up: 3/29-4/5

By Hyeongsu Park and Kathy Wang

Health Law and Policy Workshop: Petrie-Flom Fellow Nicholson Price on Making Due in Making Drugs

The Petrie-Flom Center at Harvard Law School is happy to announce the penultimate session of this year’s Health Law Policy, Biotechnology and Bioethics Workshop in the Spring 2013 semester. We’re delighted to welcome a stellar lineup of leading researchers and opinion-makers in the fields at the intersection of health and law.  Professors Elhauge and Cohen lead the 2012-13 workshop series.

This spring’s next presenter is Petrie-Flom Academic Fellow Nicholson Price. He will be presenting his paper “Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing” on Monday, April 8th  at 5pm in Hauser 105. The full text of the paper is available here, and the abstract is copied below the “read more”

The workshop will conclude on Monday, April 15th with a lecture from WilmerHale Professor of Intellectual Property Law at HLS and Faculty Director of the Berkman Center, Terry Fisher. Workshops are open to the public and copies of papers will generally be posted a week in advance on the Petrie-Flom Website: https://www.law.harvard.edu/programs/petrie-flom/workshop/index.html.

Read More

From the Editors: Technical Problem with Comment Function

Please be advised that we are currently experiencing some malfunction with the blog’s comment function. We apologize for the inconvenience and are working to have it fixed.  In the interim, if you have a comment you would like us to post on your behalf, we are happy to do so.  Send an email to hlynch at law dot harvard dot edu.

Thanks for your patience; we hope to have this issue resolved quickly.  Please note that normally, your comments should appear automatically when you hit the “post” button.

Fox on Prenatal Genetic Testing

front-page story in today’s Sunday Boston Globe quotes Bill of Health blogger Dov Fox on whether the routine use of new prenatal blood testing could “‘bring a tendency to exclude rather than accommodate people whose abilities fail to meet [certain] demands'” of modern society or “‘exert[] social pressure on parents to terminate pregnancy for fear of criticism or reproach from people who regard the[ir] choice [to have a] child with a disability [] as negligent, or irresponsible.'”
If these non-invasive tests (which look at potentially unlimited amounts of fetal DNA) were able to provide genetic information for conditions beyond just sex and health, might we come to think in similar ways about children of “merely” average looks or normal height or ordinary intelligence? Dov explored this question and others in a talk that he gave as a 2006 summer fellow at the Petrie-Flom Center. His article is called Silver Spoons and Golden Genes.

Petrie-Flom Interns’ Weekly Round-Up: 3/16-3/22

By Hyeongsu Park and Kathy Wang

Petrie-Flom Center Now Accepting Applications for 2013-14 Student Fellows

[Note: This Student Fellowship program is different from the Petrie-Flom Center Academic Fellowship, applications for which will open again in the Fall.]

The Center and Student Fellowship.  The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics is an interdisciplinary research program at Harvard Law School dedicated to the scholarly research of important issues at the intersection of law and health policy, including issues of health care financing and market regulation, biotechnology and intellectual property, biomedical research, and bioethics. The Student Fellowship Program is designed to support student research in these areas.  For more information on our current fellows and their work, see our website. 

Eligibility. The student fellowship program is open to Harvard Law School students and students in other Harvard graduate programs who are committed to undertaking a significant research project during the year of their fellowship. 

Keep reading for additional information on fellowship requirements and applications…

Read More

Registration Now Open: Petrie-Flom Annual Conference


Petrie-Flom Center Annual Conference:

The Food and Drug Administration in the 21st Century 

Friday and Saturday, May 3-4, 2013

Harvard Law School, Cambridge, MA

The Petrie-Flom Center invites you to attend our annual conference, this year entitled: “The Food and Drug Administration in the 21st Century.”  Attendance is free and open to the public.  Registration required; space is limited.

Conference Description

The Food and Drug Administration, the US government’s oldest comprehensive consumer protection agency, bears the monumental task of safeguarding the public health through regulation of food, drugs and biologics, devices, cosmetics, animal products, radiation-emitting products, and now, tobacco. The agency faces a number of perennial issues related to funding, relationships with industry, and striking the proper balance between consumer choice and consumer protection. It also faces several modern challenges related to globalization, novel technologies, newly added responsibilities, and changing threats to the public health.

How is the agency faring in the 21st century? What are the greatest challenges to the FDA’s success, and what does success look like? What lessons has it learned and how can it best meet the challenges of today? Should we keep the agency we have, pull it apart, or rebuild from scratch?   This conference will  gather leading experts from academia, government, and private industry to evaluate the FDA based on these and other questions, and to begin charting a course for the agency’s future.

Conference Sessions

* For the full conference agenda, including speakers, presentation titles, and specific times, please click here. *

DAY 1 – Friday, May 3, 2013, 9:00-5:00

  • Welcome and Introduction
  • PLENARY 1 – PETER BARTON HUTT (Covington & Burling)
  • The FDA in a Changing World
  • Preserving Public Trust and Demanding Accountability
  • LUNCH AND KEYNOTE (TBD)
  • Protecting the Public Within Constitutional Limits
  • Timing Is Everything: Balancing Access and Uncertainty
  • Major Issues in Drug Regulation

DAY 2 – Saturday, May 4, 2013, 9:00-4:00

  • Welcome
  • PLENARY 2 – ALTA CHARO (University of Wisconsin Law School)
  • Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars
  • Major Issues in Device Regulation
  • LUNCH AND PLENARY 3 – SUSAN WINCKLER (President and CEO, Food & Drug Law Institute)
  • Major Issues in Food, Supplement, and Tobacco Regulation
  • Addressing the Challenges of and Harnessing New Technologies
  • Closing Remarks

Register Now!

Questions: petrie-flom@law.harvard.edu; 617.496.4662.